Coffee and light breakfast will be served.

Patients and patient organizations are not passive recipients of science. They can be powerful drivers of discovery through their expert input and lived experience, rallying patients to provide advice or data, and advocating for further political, funding, or policy changes. This session shows the power patients can bring when they become the partners and champions driving discovery of the medicine's they need.

Transforming how we discovery medicines means transforming how we think about the drug discovery process. Drug discovery efforts using open science strategies is one of the most exciting ways people are driving innovation in this area. This session will give the audience an idea of just how far we've come, how our thinking about drug discovery and openness has expanded, and where we might go from here.

For a long time the narrative has been that open science will only work in the precompetitive space. The projects in this session are showing that isn’t true anymore. Here, we showcase some of the projects using open science to drive drug discovery right now.

The number of open data sets and tools to aid drug discovery is increasing all the time. The ease with which these tools can be accessed and used - their openness - accelerates the field and brings us closer to new medicines. This session will showcase some of the most exciting of these tools and invite the current projects and companies creating them to explain why openness is so key to the future of innovation.

The CACHE Challenges - 3 completed, 3 ongoing - have seen a fascinating variety of strategies applied to the targets chosen in the field. This session invites some of the most exciting to explain what they did, how they did it, and how you can learn from their strategies.